Lalani, A.-K. A., Li, H., Heng, D. Y., Wood, L., Kalirai, A., Bjarnason, G. A., Sim, H.-W., Kollmannsberger, C. K., Kapoor, A., Hotte, S. J., Vanhuyse, M., Czaykowski, P., Reaume, M. N., Soulieres, D., Venner, P., North, S. and Basappa, N. S. (2017) “First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience”, Canadian Urological Association Journal, 11(3-4), pp. 112–7. doi: 10.5489/cuaj.4398.